| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Triamcinolone hexacetonide (substance) |
Is a |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone diacetate (substance) |
Is a |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide (substance) |
Is a |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone adverse reaction |
Causative agent (attribute) |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone hexacetonide (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Allergy to triamcinolone (finding) |
Causative agent (attribute) |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone [endocrine use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Kenalog 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone 40mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone hexacetonide 25mg/5mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely neomycin 3.5 milligram/1 milliliter and triamcinolone acetonide 1 milligram/1 milliliter conventional release ear drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetate [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide+chlortetracycline hydrochloride 0.1/3% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing chlortetracycline and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing neomycin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing nystatin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone+econazole (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Oral triamcinolone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Parenteral triamcinolone (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Topical triamcinolone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely triamcinolone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone hexacetonide 5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone hexacetonide 20mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide |
Is a |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone dental paste |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone hexacetonide 20mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone hexacetonide 5mg/mL injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone 40mg/1mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone 80mg/2mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone hexacetonide (substance) |
Is a |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin + triamcinolone acetonide 100000unt/1mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin + triamcinolone acetonide 100000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Nystatin + triamcinolone acetonide 10000unt/1mg ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Injection of triamcinolone for local action |
Direct substance |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Injection of triamcinolone into nail bed (procedure) |
Direct substance |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Injection of triamcinolone into keloid scar (procedure) |
Direct substance |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Injection of triamcinolone |
Direct substance |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Injection of triamcinolone into keloid scar (procedure) |
Direct substance |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Injection of triamcinolone into nail bed (procedure) |
Direct substance |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing triamcinolone in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing triamcinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing triamcinolone in oropharyngeal dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Injection of triamcinolone |
Direct substance |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Injection of triamcinolone for local action |
Direct substance |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to triamcinolone (finding) |
Causative agent (attribute) |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely triamcinolone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely triamcinolone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone 4 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone hexacetonide (substance) |
Is modification of (attribute) |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone acetonide |
Is modification of (attribute) |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone diacetate (substance) |
Is modification of (attribute) |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Triamcinolone 4 mg oral tablet |
Has precise active ingredient |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely triamcinolone 1 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing triamcinolone in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing triamcinolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Neomycin- and triamcinolone-containing product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only chlortetracycline and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only econazole and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only neomycin and triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Nystatin and triamcinolone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only triamcinolone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone only product in cutaneous dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only triamcinolone in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone only product in otic dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only neomycin and triamcinolone in otic dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Triamcinolone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only econazole and triamcinolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing econazole and triamcinolone in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Triamcinolone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]